Clinical trial
A Multicenter, Open-label Study of QRX003 Lotion in Participants With Netherton Syndrome
NCT07538583 is registered in ClinicalTrials.gov with Quoin Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-label Study of QRX003 Lotion in Participants With Netherton Syndrome
- Lead sponsor
- Quoin Pharmaceuticals
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- March 19, 2026
- Completion date
- March 31, 2027
- Enrollment
- 16 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.